BriSTAR Immunotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $29.5M

  • Investors
  • 18

BriSTAR Immunotech General Information

Description

Manufacturer of engineered T-cell immunotherapy products designed to treat cancer, autoimmune disorders, and other complex diseases. The company offers proprietary STAR-T and TCR-T platforms with multi-target engagement and enhanced tumor infiltration, enabling patients and healthcare providers to achieve improved treatment outcomes in difficult-to-treat conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 4, Medical Technology Center, Life Science Park
  • Changping District
  • Beijing, 102206
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 5th Floor, Building 4, Medical Technology Center, Life Science Park
  • Changping District
  • Beijing, 102206
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BriSTAR Immunotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series C) 06-Jul-2026 $29.5M Completed Generating Revenue
10. Early Stage VC (Series B1) 15-Jul-2022 Completed Generating Revenue
9. Secondary Transaction - Private 24-Feb-2022 Completed Generating Revenue
8. Secondary Transaction - Private 03-Dec-2021 Completed Generating Revenue
7. Early Stage VC (Series B) 23-Sep-2021 Completed Generating Revenue
6. Secondary Transaction - Private 25-May-2021 Completed Generating Revenue
5. Secondary Transaction - Private 26-Jan-2021 Completed Generating Revenue
4. Early Stage VC (Series A1) 01-Jan-2020 Completed Generating Revenue
3. Early Stage VC (Series A) 21-Dec-2020 Completed Generating Revenue
2. Early Stage VC 30-Aug-2018 Completed Generating Revenue
To view BriSTAR Immunotech’s complete valuation and funding history, request access »

BriSTAR Immunotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BriSTAR Immunotech Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Loyal Valley Capital Growth/Expansion Minority
Shanghai Fudan Science Park Venture Capital Venture Capital Minority
Tsinghua Holdings Capital Growth/Expansion Minority
Yuanhui Investment Growth/Expansion Minority
Beijing Changkejin Investment Growth/Expansion Minority
You’re viewing 5 of 18 investors. Get the full list »

BriSTAR Immunotech FAQs

  • When was BriSTAR Immunotech founded?

    BriSTAR Immunotech was founded in 2018.

  • Where is BriSTAR Immunotech headquartered?

    BriSTAR Immunotech is headquartered in Beijing, China.

  • What is the size of BriSTAR Immunotech?

    BriSTAR Immunotech has 100 total employees.

  • What industry is BriSTAR Immunotech in?

    BriSTAR Immunotech’s primary industry is Drug Discovery.

  • Is BriSTAR Immunotech a private or public company?

    BriSTAR Immunotech is a Private company.

  • What is BriSTAR Immunotech’s current revenue?

    The current revenue for BriSTAR Immunotech is .

  • How much funding has BriSTAR Immunotech raised over time?

    BriSTAR Immunotech has raised $81.7M.

  • Who are BriSTAR Immunotech’s investors?

    Loyal Valley Capital, Shanghai Fudan Science Park Venture Capital, Tsinghua Holdings Capital, Yuanhui Investment, and Beijing Changkejin Investment are 5 of 18 investors who have invested in BriSTAR Immunotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process